Type 2 diabetes

Citations 201-210 of 286 total displayed.

Past content (since Dec 2000):

Scientific Contributions
Interaction Between an 11HSD1 Gene Variant and Birth Era Modifies the Risk of Hypertension in Pima Indians

Paul W. Franks, William C. Knowler, Saras Nair, Juraj Koska, Yong-Ho Lee, Robert S. Lindsay, Brian R. Walker, Helen C. Looker, Paska A. Permana, P. Antonio Tataranni, and Robert L. Hanson
Hypertension published September 27, 2004, doi:10.1161/01.HYP.0000144294.28985.d5 [Abstract]  

Editorial Commentary
Peroxisome Proliferator-Activated Receptors Ligands, Oxidative Stress, and Cardiac Fibroblast Extracellular Matrix Turnover

Francisco J. Villarreal and Juan Asbun
Hypertension published September 20, 2004, doi:10.1161/01.HYP.0000144401.18602.67 [Abstract]  

Scientific Contributions
Clinical Outcomes in the Diabetes Cohort of the International Verapamil SR-Trandolapril Study

George L. Bakris, Efrain Gaxiola, Franz H. Messerli, Giuseppe Mancia, Serap Erdine, Rhonda Cooper-DeHoff, Carl J. Pepine; for the INVEST Investigators
Hypertension published September 20, 2004, doi:10.1161/01.HYP.0000143851.23721.26 [Abstract]  

Scientific Contributions
Effect of Angiotensin-Converting Enzyme Inhibition on Survival in 3773 Chinese Type 2 Diabetic Patients

Wing Yee So, Risa Ozaki, Norman N. Chan, Peter C.Y. Tong, Chung Shun Ho, Christopher W.K. Lam, Gary T.C. Ko, Chun Chung Chow, Wing Bun Chan, Ronald C.W. Ma, and Juliana C.N. Chan
Hypertension 2004;44:294-299; published online before print as doi:10.1161/01.HYP.0000137192.19577.c3 [Abstract] [Full text]  

Editorial Commentaries
Mediastinal Fat, Insulin Resistance, and Hypertension

Arya M. Sharma
Hypertension 2004;44:117-118; published online before print as doi:10.1161/01.HYP.0000137993.70745.82 [Full text]  

Editorial Commentary
Mediastinal Fat, Insulin Resistance, and Hypertension

Arya M. Sharma
Hypertension published July 12, 2004, doi:10.1161/01.HYP.0000137993.70745.82 [Abstract]  

Scientific Contributions
Effect of Angiotensin-Converting Enzyme Inhibition on Survival in 3773 Chinese Type 2 Diabetic Patients

Wing Yee So, Risa Ozaki, Norman N. Chan, Peter C.Y. Tong, Chung Shun Ho, Christopher W.K. Lam, Gary T.C. Ko, Chun Chung Chow, Wing Bun Chan, Ronald C.W. Ma, and Juliana C.N. Chan
Hypertension published July 12, 2004, doi:10.1161/01.HYP.0000137192.19577.c3 [Abstract]  

Brief Reviews
Is There a Rationale for Angiotensin Blockade in the Management of Obesity Hypertension?

Arya M. Sharma
Hypertension 2004;44:12-19; published online before print as doi:10.1161/01.HYP.0000132568.71409.a2 [Abstract] [Full text]  

Scientific Contributions
Sex Differences in Age-Related Stiffening of the Aorta in Subjects With Type 2 Diabetes

Lorenita De Angelis, Sandrine C. Millasseau, Andrew Smith, GianCarlo Viberti, Richard H. Jones, James M. Ritter, and Philip J. Chowienczyk
Hypertension 2004;44:67-71; published online before print as doi:10.1161/01.HYP.0000130482.81883.fd [Abstract] [Full text]  

Brief Reviews
Is There a Rationale for Angiotensin Blockade in the Management of Obesity Hypertension?

Arya M. Sharma
Hypertension published June 1, 2004, doi:10.1161/01.HYP.0000132568.71409.a2 [Abstract]  

[First page]   [Previous page]   [Next page] Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29